MedDataX Logo

Motivational Interviewing for Vaccine Uptake in Latinx Adults

NCT06062056 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3698

Last updated 2025-09-15

No results posted yet for this study

Summary

The goal of this clinical trial is to test whether modified behavioral health services, integrating motivational interviewing, will reduce vaccine hesitancy and increase uptake for the COVID-19 and influenza vaccines among Latinx adults with mental illness.

Conditions

  • Vaccine Hesitancy

Interventions

OTHER

EHR alert

An EHR alert will be fired if a behavioral health patient is missing a COVID-19 or influenza vaccine.

BEHAVIORAL

Motivational Interviewing

In response to the alert and using support tools in the EHR, the behavioral health clinician will integrate motivational interviewing into the counseling session to discuss vaccine hesitancy (if it is deemed appropriate based on patient needs and clinical judgment).

BEHAVIORAL

Warm hand off to nurse

For patients interested in vaccination following motivational interviewing, the behavioral health clinician will do a warm hand off to a nurse for vaccination

Sponsors & Collaborators

  • East Boston Neighborhood Health Center

    collaborator UNKNOWN

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Boston College

    lead OTHER

Principal Investigators

  • Kirsten Davison, PhD · Boston College

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06062056 on ClinicalTrials.gov